NESA non-invasive neuromodulation is based on an imperceptible superficial treatment of electrical microcurrents generated by the XSignal device, through low resistance areas of the skin. The biostimulatory effect of the electrical current is multiplied thanks to the 24 entry routes that structurally cover the entire body, through 4 electrodes, one on each extremity, and a fifth electrode called a director.

NESA technology was created based on the basic principle of electrical stimulation for autonomic nervous system and pain modulation. These electrical stimuli produce variations in neuronal electrical potentials, imitating different electrical patterns. Developed at the end of the 20th century, thanks to a team of Japanese scientists and engineers, 10 years of trial-error studies allowed us to establish the low resistance input nerve pathways used today, and also the electrical sequences of each program as well as the effects produced. The objective was, and continues to be, to achieve results through the use of a minimal but adequate current to influence the organism's information processing system. In this sense, the NESA microcurrent generator allows the entry of the electrical signal (input) and creates the possibility of modulating the nervous system through a current without polar effects, without side effects, imperceptible (for the vast majority of people) and capable of modulating small-caliber nerve fibers.

NESA global neuromodulation can be applicable to different clinical scenarios. In the case of dysfunctions or symptoms secondary to the excitement and tension of the brain and nervous, musculoskeletal, visceral and/or vascular systems, this technology restores functions in the medium/long term, as if it were a training of the nervous system. . It is also indicated in those conditions that require the restoration of sleep quality and cases in which there are complications with psychosomatic consequences, imbalances or involvement of the autonomic nervous system.
For this reason, NESA , Parkinson's, Alzheimer's...

Contact us

Skip to content